keyword
MENU ▼
Read by QxMD icon Read
search

Quo vadis

keyword
https://www.readbyqxmd.com/read/29625709/digital-pathology-quo-vadis
#1
EDITORIAL
Eric F Glassy
No abstract text is available yet for this article.
April 3, 2018: Pathology
https://www.readbyqxmd.com/read/29610775/editorial-digital-complete-dentures-quo-vadis
#2
Bernd Kordaß
No abstract text is available yet for this article.
2018: International Journal of Computerized Dentistry
https://www.readbyqxmd.com/read/29610128/renin-angiotensin-aldosterone-system-inhibitors-for-right-ventricular-dysfunction-in-tetralogy-of-fallot-quo-vadis
#3
EDITORIAL
Sushma Reddy, Daniel Bernstein, Jane W Newburger
No abstract text is available yet for this article.
April 3, 2018: Circulation
https://www.readbyqxmd.com/read/29606064/ketamine-quo-vadis
#4
Charles B Nemeroff
No abstract text is available yet for this article.
April 1, 2018: American Journal of Psychiatry
https://www.readbyqxmd.com/read/29589875/evidence-based-medicine-2018-quo-vadis
#5
EDITORIAL
Andrew Miles
No abstract text is available yet for this article.
February 2018: Journal of Evaluation in Clinical Practice
https://www.readbyqxmd.com/read/29553749/drug-delivery-in-cancer-therapy-quo-vadis
#6
Zheng-Rong Lu, Peter Qiao
The treatment of malignancies has undergone dramatic changes in the past few decades. Advances in drug delivery techniques and nanotechnology have allowed for new formulations of old drugs, so as to improve the pharmacokinetics, to enhance accumulation in solid tumors, and to reduce the significant toxic effects of these important therapeutic agents. Here, we review the published clinical data in cancer therapy of several major drug delivery systems, including targeted radionuclide therapy, antibody-drug conjugates, liposomes, polymer-drug conjugates, polymer implants, micelles, and nanoparticles...
March 22, 2018: Molecular Pharmaceutics
https://www.readbyqxmd.com/read/29547420/smarttots-quo-vadis
#7
Laszlo Vutskits
No abstract text is available yet for this article.
April 2018: Anesthesia and Analgesia
https://www.readbyqxmd.com/read/29490803/quo-vadis-point-of-care-diagnostics-report-ii-of-the-swiss-symposium-in-point-of-care-diagnostics-2017
#8
Marc E Pfeifer
U.S. studies show that the global point-of-care (POC) diagnostics market will reach $40.5 bn by 2022, with a compound annual growth rate (CAGR) of 10%. This is one of the reasons why HES-SO Valais-Wallis and CSEM, acting on behalf of the NTN Swiss Biotech thematic platform in vitro Diagnostics (TP IVD), invited interested parties on October 26, 2017 to the SWISS SYMPOSIUM in Point-of-Care Diagnostics (see CHIMIA No. 12/2017). We now bring the second report on the future prospects of POC diagnostics.
February 1, 2018: Chimia
https://www.readbyqxmd.com/read/29462830/-quo-vadis-data-linkage-in-germany-an-initial-inventory
#9
Stefanie March, Manfred Antoni, Joachim Kieschke, Bianca Kollhorst, Birga Maier, Gabriele Müller, Murat Sariyar, Mandy Schulz, Swart Enno, Jan Zeidler, Falk Hoffmann
In recent years, linking different data sources, also called data linkage or record linkage, to address scientific questions, is being increasingly used in Germany. However, there are very few published reports and new projects develop the necessary tools independently of each other. Therefore, a team of researchers joined together to exchange their experiences on data linkage and to give suggestions on how linkage could be done for scientists, reviewers as well as members of data privacy boards and ethics committees...
February 20, 2018: Das Gesundheitswesen
https://www.readbyqxmd.com/read/29367715/biomarkers-in-chronic-graft-versus-host-disease-quo-vadis
#10
D Wolff, H Greinix, S J Lee, T Gooley, S Paczesny, S Pavletic, F Hakim, F Malard, M Jagasia, A Lawitschka, J A Hansen, D Pulanic, E Holler, A Dickinson, E Weissinger, M Edinger, S Sarantopoulos, K R Schultz
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications including the first biomarker-driven interventional trials of acute graft-versus-host disease (GvHD). In contrast, the development of biomarkers of chronic GvHD (cGvHD) has lagged behind due to a broader variety of manifestations, overlap with acute GvHD, a greater variation in time to onset and maximum severity, and lack of sufficient patient numbers within prospective trials. An international workshop organized by a North-American and European consortium was held in Marseille in March 2017 with the goal to discuss strategies for future biomarker development to guide cGvHD therapy...
January 24, 2018: Bone Marrow Transplantation
https://www.readbyqxmd.com/read/29341367/development-of-antibody-directed-therapies-quo-vadis
#11
Tiago Rodrigues, Gonçalo J L Bernardes
Less is more: The efficacy of antibody-drug conjugates (ADCs) for cancer therapy is traditionally associated with cleavable linkers for payload release. Evidence now suggests that simpler constructs without cleavable moieties can afford more stable and effective ADCs.
January 17, 2018: Angewandte Chemie
https://www.readbyqxmd.com/read/29239956/the-anesthesia-workstation-quo-vadis
#12
Jan F A Hendrickx, Andre M De Wolf
Ensuring adequate ventilation and oxygenation and delivering inhaled anesthetic agent to the patient remain core responsibilities of the anesthesia provider during general anesthesia. Because of the emphasis placed on physiology, pharmacology, clinical sciences, and administrative duties, the stellar anesthesia workstation technology may be underutilized by the anesthesia community. Target-controlled O2 and agent delivery and automated end-expired CO2 control have entered the clinical arena, with only cost, luddism, and administrative hurdles preventing their more widespread use...
December 11, 2017: Anesthesia and Analgesia
https://www.readbyqxmd.com/read/29226585/block-copolymer-self-assembly-in-solution-quo-vadis
#13
REVIEW
Johannes C Brendel, Felix H Schacher
The desire to increase complexity while maintaining control over every aspect of the process itself might be used as a provocative description of the developments in block copolymer self-assembly in solution over the last decade. The community has witnessed tremendous progress, not only with regard to the design of building blocks, but also in terms of understanding assembly pathways, interfacial properties, or kinetic obstacles. In particular, the latter can be of interest (and actually turned into an advantage) if structures that are not in thermodynamic equilibrium are targeted...
February 2, 2018: Chemistry, An Asian Journal
https://www.readbyqxmd.com/read/29212333/-quo-vadis-diabetes-technology
#14
George Grunberger
Management of patients with diabetes mellitus who require intensive insulin therapy has changed dramatically. From urine and then whole blood glucose monitoring patients can now wear personal continuous glucose monitors; from using multiple insulin injections they can now deliver subcutaneous insulin continuously using ever-more sophisticated insulin pumps. With the current integration of continuous glucose monitoring and insulin pumps a new era is arriving when "smart" insulin pumps can automate insulin delivery to assure more stable glycemic control while minimizing episodes of hypoglycemia...
2017: Casopís Lékar̆ů C̆eských
https://www.readbyqxmd.com/read/29212332/quo-vadis-diabetes-technology
#15
George Grunberger
Management of patients with diabetes mellitus who require intensive insulin therapy has changed dramatically. From urine and then whole blood glucose monitoring patients can now wear personal continuous glucose monitors; from using multiple insulin injections they can now deliver subcutaneous insulin continuously using ever-more sophisticated insulin pumps. With the current integration of continuous glucose monitoring and insulin pumps a new era is arriving when "smart" insulin pumps can automate insulin delivery to assure more stable glycemic control while minimizing episodes of hypoglycemia...
2017: Casopís Lékar̆ů C̆eských
https://www.readbyqxmd.com/read/29169475/outcomes-in-pediatric-dilated-cardiomyopathy-quo-vadis
#16
EDITORIAL
Robert G Weintraub, Peta M A Alexander
No abstract text is available yet for this article.
November 28, 2017: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/29079546/congenital-disorders-of-glycosylation-cdg-quo-vadis
#17
REVIEW
Romain Péanne, Pascale de Lonlay, François Foulquier, Uwe Kornak, Dirk J Lefeber, Eva Morava, Belén Pérez, Nathalie Seta, Christian Thiel, Emile Van Schaftingen, Gert Matthijs, Jaak Jaeken
The survey summarizes in its first part the current status of knowledge on the Congenital Disorders of Glycosylation (CDG) with regard to their phenotypic spectrum, diagnostic and therapeutic strategies, and pathophysiology. It documents the clinical and basic research activities, and efforts to involve patients and their families. In the second part, it tries to look into the future of CDG. More specific biomarkers are needed for fast CDG diagnosis and treatment monitoring. Whole genome sequencing will play an increasingly important role in the molecular diagnosis of unsolved CDG...
October 24, 2017: European Journal of Medical Genetics
https://www.readbyqxmd.com/read/29045164/ehealth-literacy-research-quo-vadis
#18
Lena Griebel, Heidi Enwald, Heidi Gilstad, Anna-Lena Pohl, Julia Moreland, Martin Sedlmayr
The concept of electronic health (eHealth) literacy evolved from the social and information sciences and describes competencies necessary to use electronic health services. As it is a rather new topic, and as there is no current overview of the state of the art in research, it is not possible to identify research gaps. Therefore, the objective of this viewpoint article is to increase knowledge on the current state of the art of research in eHealth literacy and to identify gaps in scientific research which should be focused on by the research community in the future...
October 18, 2017: Informatics for Health & Social Care
https://www.readbyqxmd.com/read/28958605/quo-vadis-probiotics-human-research-supports-further-study-of-beneficial-microbes-in-mental-health
#19
Martin A Katzman, Alan C Logan
No abstract text is available yet for this article.
October 2017: EBioMedicine
https://www.readbyqxmd.com/read/28952620/organoactinides-in-catalytic-transformations-scope-mechanisms-and-quo-vadis
#20
Heng Liu, Tapas Ghatak, Moris S Eisen
The last decade has witnessed wonderful and remarkable advances in the chemistry of early actinides, providing information on not only the reactivity of these types of compounds in stoichiometric reactions but also their utilization in challenging catalytic processes. This canvas of knowledge allows the design of chemical reactivities to reach a high level of sophistication. As compared to early/late transition metal and lanthanide complexes, the actinides display complementary and in some cases real unique performances for similar organic transformations...
October 12, 2017: Chemical Communications: Chem Comm
keyword
keyword
68327
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"